Keywords: patients, likely, stay, pfizer, lipitor, simvastatin, says

Patients more likely to stay on Pfizer's Lipitor than simvastatin, says managed care database study

Article | 21 July 2008

Print This

World drug giant Pfizer says that new statin users who took Lipitor (atorvastatin calcium) were significantly more likely to stay ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in